Anastrozole is a medication primarily used in the treatment of breast cancer, specifically targeting hormone receptor-positive breast cancer. This drug belongs to a class of medications known as aromatase inhibitors, which play a crucial role in lowering estrogen levels in the body. By doing so, Anastrozole effectively inhibits the growth of cancer cells that require estrogen for proliferation.
Anastrozole（アナストロゾール）は、乳がんの治療に使用される薬物であり、エストロゲン受容体陽性の乳がん細胞の成長を抑制する作用があります。この作用により、腫瘍の成長を防ぎ、がんの進行を抑制します。Anastrozoleの詳細については、 Anastrozole のページをご覧ください。
Mechanism of Action
Anastrozole functions by:
- Aromatase Inhibition: It inhibits the aromatase enzyme, essential for converting androgens into estrogens.
- Estrogen Level Reduction: Reducing estrogen levels in postmenopausal women helps starve estrogen-dependent tumors.
- Slowing Tumor Growth: By limiting the availability of estrogen, Anastrozole slows the progression of tumors that flourish in the presence of this hormone.
Clinical Applications
Anastrozole is commonly indicated for:
- Adjuvant treatment of early-stage estrogen receptor-positive breast cancer.
- Treatment of advanced breast cancer in postmenopausal women.
- Reducing the risk of breast cancer recurrence.
Conclusion
In summary, Anastrozole is an essential therapeutic option for managing hormone-sensitive breast cancer. Understanding its pharmacological action can aid healthcare providers in optimizing treatment plans for patients combating this disease.